chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe hair loss/On the left side of my head I had the bald spot 4 cm in diameter bald no hair; physiological traumatic; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6199), via an unspecified route of administration, administered in the left arm on 07Mar2021 14:15 (at the age of 56 years old) at a single dose for COVID-19 immunization. Vaccination was done in a hospital. Medical history included type 1 diabetes, psoriasis and sensitive immune system, all from an unknown date and unknown if ongoing. The patient was not pregnant. There was no other vaccine in four weeks. There were no known allergies. Concomitant medications included insulin taken for type 1 diabetes mellitus, start and stop date were not reported.  The patient experienced severe hair loss/on the left side of my head i had the bald spot 4 cm in diameter bald no hair and physiological traumatic, both on 08Mar2021 07:30. It was reported that after the vaccination, on 08Mar2021, the patient had severe hair loss and now she has a bald spot of 4 centimeters. The patient's hair started falling out but she didn't think much of it, from time you brush your hair it just happens but as the day progressed they just kept falling out and she had very thick bulky hair and she didn't even look the same and on the left side of her head which was weird because that was the side where she got the shot, on the left side of her head , she had the bald spot 4 cm in diameter bald no hair. Her hair still continues to fall and she can't brush it or touch it because it becomes more severe. As the day progressed, they just kept falling out. This was emotionally, it's horrible, it's like losing part of her body. No treatment was received.  She doesn't even know what to do, she went to the doctor today to talk to them about that and then she was going to the dermatologist on Thursday, She never had that in her life. Today is 16Mar2021, and her hair was still falling. It was also reported that she is looking for justice since this is physiologically traumatic. She was scared to wash her hair. It was reported that the events resulted in disability/permanent damage. No treatment was received. There was no COVID prior vaccination and not COVID tested post vaccination. The patient underwent lab tests and procedures which included Hemoglobin A1-C: 6.2 (average blood sugar is 6.2) on an unspecified date. The outcome of the events was not recovered.
Patient reported throat/tonsils swelling, patient was monitored for 10 minutes.  Then patient reported tongue swelling, patient was talking normal, able to swallow.  Vital signs: HR: 72, O2: 98.  EMS called, 25mg Benadryl IM given.  Patient transferred to  Hospital .
Diarrhea; Nausea; Lightheaded; Anxious; Vomiting; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 23Jul2021at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, allergy to nickel and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included daily vitamins (unspecified), azithromycin (MANUFACTURER UNKNOWN) and guaifenesin (MUCINEX) for unknown indications from an unknown date and unknown if ongoing. The patient previously took promethazine hydrochloride / dextromethorphan hydrobromide (PROMETHAZINE DM) and amoxicillin / clavulanic acid (AUGMENTIN) for unknown indications on an unknown date and experienced drug allergy. On 23Jul2021 at 16:45, the patient experienced diarrhea, nausea, lightheaded, anxious and vomiting. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, nausea, lightheaded, anxious and vomiting were recovered on unknown date in Jul2021.  No follow-up attempts are possible. No further information is expected.
Child was being held in lap by mother. Child pulled away when needle entered L thigh. Dose was not administered and wasted. Child was revaccinated with new dose and syringe.
sore arm; body aches; felt bad all day; Nauseous; fever; chills; feels tired; A spontaneous report was received from a consumer concerning a 53-year old, female patient who received Moderna's COVID-19 vaccine and experienced fever, body ache, chills, nausea, sore arm, feeling bad, and feeling tired.   The patient's medical history, as provided by the reporter, included hypertension, high cholesterol, pre-diabetes, and total hysterectomy. Concomitant medications reported included progesterone, testosterone, telmisartan, and estradiol/estriol for drug use for unknown indication.    On 02 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (025L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 02 Jan 2021, the patient experienced nausea and a sore arm after vaccination. Five hours late, she reported having chills, a fever of 102 degrees Fahrenheit, and feeling bad all day. The symptoms lasted about 18 hours, however patient was still feeling tired at the time of report. No treatment was provided.    Action taken with mRNA-1273 in response to the event was not reported.   The events, fever, body ache, chills, nausea, sore arm and feeling bad, were considered recovered/resolved on 03 Jan 2021.  The outcome of the event, feeling tired, was unknown/not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Red erythema; soreness at the site of injection.; Fatigue; headache; myalgias; fever; chills; This is a spontaneous report from a contactable other hcp.  A 26-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Lot Number: EM9809), via an unspecified route of administration, administered in left arm on 18Feb2021 03:45 (age at vaccination 26-year-old) as single dose for COVID-19 immunisation.  Medical history included ehlers-danlos syndrome, psoriasis from an unknown date and unknown if ongoing. She did not have any known allergies. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. On 19Feb2021 03:00, the patient experienced red erythema, soreness at the site of injection, fatigue, headache, myalgias, fever, chills. Therapeutic measures were taken as a result of red erythema, soreness at the site of injection, fatigue, headache, myalgias, fever, chills. Treatment included Tylenol temporarily relieved arm soreness. It was reported that there was no COVID prior vaccination. and did not had COVID tested post vaccination.The seriousness of events was non-serious. The outcome of all the events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
NO ADVERSE REACTION NOTED. PATIENT SHOULD HAVE RECEIVED PFIZER VACCINE DUE TO AGE
Patient described Hive, approximately 3 inches in diameter on her left thigh, Intermittent fever and "Bone Aches".   Patient reported taking OTC analgesic and antihistamine.   Otherwise did not seek Medical Attention.
Pt recvd 3 doses of Engerix-B 29NOV90 & 27DEC90 & 28MAY91 & it was determined that pt was a non-converter; no treatment given;
0.1ML OF VACCINE LEFT IN SYRINGE AFTER ADMINISTRATION; This spontaneous report received from a patient concerned multiple patients. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced 0.1ml of vaccine left in syringe after administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 0.1ml of vaccine left in syringe after administration was not reported. This report was non-serious. This case, from the same reporter is linked to 20210431378.
On 11/7/90, developed chills, nausea, 103 fever, achiness, lasted 24-36 hrs treated w/aspirin/rest. 11/12/90 severe allergic rxn, hives on arms, neck, back, legs, face & throat. ER gave adrenaline inject. Treated hives w/Benadryl.
Over the course of 24 hours, a red, swollen bump appeared. The bump is approximately 1 1/2 in. in diameter. Patient stated some soreness in the right arm. Treatment: MOTRIN/ADVIL.
I received my vaccine on 05/27/2022 without any issues. The week of 06/06/2022, I started having this constant cough with excessive mucus. I have seen multiple doctors and they can't diagnose what is wrong. I have been on three rounds of antibiotics and two rounds of steroids. I have tried multiple over the counter medications, but nothing helps. I take ten to twenty-five cough a day. The ENT doctor recommended to see an allergist.
Diarrea, fever, troubled breathing, chills, shaking, dehydration Tylenol and limited monitoring. Patient was concerned that they nearly died due to not having proper care
Information has been received from a mother concerning her 17 year old daughter who with an allergy to "Zithromax", on 02-JUL-2008 was vaccinated with her third dose of GARDASIL vaccine (yeast) (Lot# not reported). Concomitant therapy included hormonal contraceptives (unspecified). The mother reported that the patient was always tired after receiving the first and second doses of GARDASIL vaccine (yeast) (Lot# not reported). On 02-JUL-2008 reported as "within a day or so" the patient experienced tiredness, nausea and chills. At the time of reporting, the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 8/14/2008. Follow-up information was received from a certified medical assistant concerning a 17 year old female student with no drug allergies who on 02-Jul-2008 was vaccinated with the third dose of GARDASIL (Lot # 659182/1757U). On 02-Jul-2008 the patient experienced headaches, tiredness and nausea. The patient recovered from headache, tiredness and nausea after only two weeks. There was no illness at time of vaccination. Additional information has been requested.
pt recvd vax 18JAN93 & 1/2 hr following vax devel a rash; 2FEB93 rash persisted; No further details were provided;
Headache, Arthralgia, Fever, stiff neck, back pain Narrative: onset of s/s in late afternoon day of shot missed two days of work.
Moderna COVID-19 Vaccine  Nausea/Vomiting/Diarrhea upon awakening on 12/24. Lightheaded, near-syncope, diaphoretic. Lasted approximately 3 hours. Vomited then nausea subsided after about 1hr.  Chills starting 12/26. Difficulty warming up after being outside in the cold. Prolonged effects that are not normal for me. 12/28 cold/clammy hands despite being in warm environment.
Itchiness, Redness and swelling around injection site the day after vaccines administered. Blister and rash 2 days after administration of vaccines.
In approximately 4 hours after the vaccine I started to get a headache and muscle aches. In  about 6-7 hours I started itching.  I didn't feel good so I went to sleep early.  The next morning the symptoms worsen I had a horrible headache and body aches.  I was very itchy and I notice I had a rash and some hives.  I called the urgent care is my primary care.  I did a phone appointment with the physician in charge at urgent care.  I sent photos of my Face, Chest and Arms with the rash.    I was then instructed to take Benadryl which is what I had on hand.  I was given a prescription antihistamine.  After taking it and taking Advil for the muscle pain.  The symptoms subsided.    The rash and hives disappeared.  I had some redness for the day and a little bit of itching.   The muscle aches and headache continued for a total of 3 days.    I was advised not to take the second dose.  Later my doctor prescribed an epipen and said it was up to me if I wanted to take the second dose.   I chose not to take the second dose.
This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 69-year-old female patient who received Shingrix for prophylaxis. Previously administered products included Paracetamol (hives and rash), morphine (nausea), erythromycin (hives and rash), sulfa (hives and rash) and prednisone (hives and rash). On 9th May 2018, the patient received the 1st dose of Shingrix. On 10th May 2018, 1 days after receiving Shingrix, the patient experienced injection site rash and injection site itching. The patient was treated with Benadryl. On an unknown date, the outcome of the injection site rash and injection site itching were recovering/resolving. It was unknown if the reporter considered the injection site rash and injection site itching to be related to Shingrix. Additional details were provided as follows: The reporter was not sure if this was related to the product or not, but reported she had a constant itching and rash area of her right upper arm that began one day after vaccination on 10th May 2018. She stated it had improved but not resolved. She was using Benadryl cream at night. Reporter did not have paperwork on the vaccination dose, site or route of the product, but noted she believed it was in the fatty part toward the back of her right upper arm. She had notified her physician of the events.
Rash 1. Anterior chest, both upper arms and posterior back to the waist Benadryl
I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
I experienced nerve pain on the left side of my leg and I took my nerve pain medication (Gabapentin 300mg) and it lessen the symptoms. The next day during breakfast/lunch and after going to my bedroom, I fell down on the bed and started to feel as though I was having a stroke (BP went to 265/90+ and my normal is 120/70, neck pain, and was as though I was dying). One hour later the same symptoms appear and I went to see my doctor who took my blood pressure and it was elevated. The doctor told me to take two Tylenol and two Advil's alternating every 4 hours. I also experienced a fever. I was finally able to overcome the symptoms after taking one does of Tylenol and Advil.
NUMBNESS IN BOTH ARMS; BURNING SENSATION IN THE LEGS; SEVERE HEADACHE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 15-MAR-2021, the subject experienced numbness in both arms. On 15-MAR-2021, the subject experienced burning sensation in the legs. On 15-MAR-2021, the subject experienced severe headache. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from numbness in both arms, and burning sensation in the legs, and had not recovered from severe headache. This report was non-serious.
1/28/15 1730 fever 102 TYLENOL given. 1/29/15 0830 fever 103 degrees - TYLENOL given. 1/29/15 1220 fever 103.7 degrees took to ER. 103.5 after MOTRIN given. x2 episodes of dazed look and shaking. 1/30/15 100 degrees at 0600 TYLENOL given. 1/30/15 1300 normal temp. Dx fever, febrile seizure.
Second dose of RabAvert was administered four days after the first dose; Case reference number US-BN-2022-004671, is a spontaneous case report initially received from a nurse (reference number: USBAV22-1952) on a 14-Nov-2022 and concerns a 24-year-old male patient.   The patient's medical history was not provided.   *The patient's concomitant medication were Motrin (ibuprofen) and Tylenol (paracetamol)*.   As reported, the patient was healthy.  On 10-Nov-2022, the patient was vaccinated with the first dose of RabAvert (rabies virus (inactivated, strain flury LEP); batch number: YRBA841A), at a dose 1 mL, administered intramuscularly, *into left deltoid* and for pre-exposure rabies immunization.  On 14-Nov-2022, four days after the first dose, the patient was vaccinated with the second dose of RabAvert (batch number: YRBA841A), at a dose 1 mL, administered intramuscularly, *into right deltoid* and for pre-exposure rabies immunization (explicitly coded as 'inappropriate schedule of vaccine administered').  *The patient did not experience any adverse events. *  *The reporter assessed the event as non-serious and non-related. *   Additional information received from Bavarian Nordic on 14-Nov-2022 included the local case ID.  All follow-up information's' are blended into the case narrative above, with the latest information presented between asterisks (*).  Follow-up information received from nurse on 17-Nov-2022 included patient's date of birth and concomitant medication's, vaccine details: date of vaccination, anatomical site location for first and second dose of RabAvert vaccine and seriousness.; Reporter's Comments: A 24-year-old male patient was vaccinated with the second dose of RabAvert four days after the first dose for pre-exposure rabies immunization, which is considered as inappropriate schedule of vaccine administered. 1 mL dose was applied intramuscularly into the right deltoid. The patient did not experience any adverse events. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to RabAvert, but to a human factor. The case is non-serious.; Sender's Comments: A 24-year-old male patient was vaccinated with the second dose of RabAvert four days after the first dose for pre-exposure rabies immunization, which is considered as inappropriate schedule of vaccine administered. 1 mL dose was applied intramuscularly into the right deltoid. The patient did not experience any adverse events. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to RabAvert, but to a human factor. The case is non-serious.
patient had flu after taking the flu shot; Initial information was received on 14-Oct-2020 regarding an unsolicited valid non-serious case from a consumer.  This case involves a patient (unknown demographics) who had flu (influenza) while he/she received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on batch number for this case.
No adverse effect reported; improperly stored VARlVAX; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information on pertinent medical history, concomitant medication and drug allergies/reactions was not reported.  On 12-SEP-2019 the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection (Lot # S005078, expiration date 19-FEB-2021 or lot # R019237, expiration date 04-JUL-2020; dose, frequency and route were not provided) for prophylaxis. The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored sterile diluent.  The administered dose of the vaccine experienced a temperature excursion -14 degree Celsius to -10 degree Celsius (-9.74 C) for an unknown time frame. There was no previous temperature excursion. The digital data logger was involved.  There was no adverse effect reported.
c/o CP within 10 minutes of admin then a headache. CP resolved after 10 minutes. Given Tylenol of HA. Refused transport to ER. D/C'ed home.
PATIENT CALLED AND STATED THAT SHE HAD RECEIVED 2 VACCINES THIS WEEKEND AT OUR PHARMACY. WHEN SHE TOOK OFF HER CLOTHING LATER THAT EVENING, SHE NOTICED AN ENTIRE BODY RASH, MOSTLY ON THE TOPS OF HER THIGHS, CONSISTING OF WHEALS AND WELTS THAT WERE DIME TO QUARTER SIZED AND SLIGHTLY RAISED. SHE SAID THEY WERE RED, BUT ARE SLOWLY STARTING TO LIGHTED. SHE SAID ABOUT AN HOUR AFTER THE VACCINE THE SKIN ON HER NECK GOT SLIGHTLY ITCHY, BUT SHE DIDN'T THINK MUCH ABOUT IT. NO BREATHING ISSUES HAVE OCCURED
Started Friday after vaccine. Arm pain (Lt)  Proceeded to inability to move or lift arm Abdominal pain, severe nausea progressed to vomiting. Increased fatigue, and sleep.  Diarrhea This day Wednesday 6/26/19 continue to have abdominal pain.
Pt is having trouble lifting arm rotating arm, soreness, nausea, joint ache, chills.
Two days post vax, the pt experienced malaise, lymphadenopathy, and generalized body rash. Shortly after 4/26/00, the vaccinee was seen by the physician and she had severe exudative pharyngitis that was positive for Group A Streptococcus. She received the appropriate treatment, continued the physician, and did quite well.